Cargando…

Emerging Therapies for Dystrophic Cardiomyopathy

[Figure: see text]

Detalles Bibliográficos
Autores principales: Garry, Daniel J., Alexy, Tamas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978550/
https://www.ncbi.nlm.nih.gov/pubmed/31999276
http://dx.doi.org/10.1016/j.jacbts.2019.10.003
_version_ 1783490725059493888
author Garry, Daniel J.
Alexy, Tamas
author_facet Garry, Daniel J.
Alexy, Tamas
author_sort Garry, Daniel J.
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-6978550
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69785502020-01-29 Emerging Therapies for Dystrophic Cardiomyopathy Garry, Daniel J. Alexy, Tamas JACC Basic Transl Sci Editorial Comment [Figure: see text] Elsevier 2019-11-25 /pmc/articles/PMC6978550/ /pubmed/31999276 http://dx.doi.org/10.1016/j.jacbts.2019.10.003 Text en © 2019 Published by Elsevier on behalf of the American College of Cardiology Foundation. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial Comment
Garry, Daniel J.
Alexy, Tamas
Emerging Therapies for Dystrophic Cardiomyopathy
title Emerging Therapies for Dystrophic Cardiomyopathy
title_full Emerging Therapies for Dystrophic Cardiomyopathy
title_fullStr Emerging Therapies for Dystrophic Cardiomyopathy
title_full_unstemmed Emerging Therapies for Dystrophic Cardiomyopathy
title_short Emerging Therapies for Dystrophic Cardiomyopathy
title_sort emerging therapies for dystrophic cardiomyopathy
topic Editorial Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978550/
https://www.ncbi.nlm.nih.gov/pubmed/31999276
http://dx.doi.org/10.1016/j.jacbts.2019.10.003
work_keys_str_mv AT garrydanielj emergingtherapiesfordystrophiccardiomyopathy
AT alexytamas emergingtherapiesfordystrophiccardiomyopathy